531157 (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective February 23, 2026, including 2 new additions, 7 … | |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective February 23, 2026, including 2 new additions, 7 upgrades to higher ESM stages, 9 downgrades to lower ESM stages, and 18 securities exiting the framework.
| |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective February 23, 2026, including 2 new securities added, 7 … | |||||||||||||||
BSE announces changes to the Enhanced Surveillance Measure (ESM) framework effective February 23, 2026, including 2 new securities added, 7 moved to higher stages, 9 moved to lower stages, and 18 securities removed from ESM.
| |||||||||||||||
BSE revises price bands for 20 scrips including Aerpace Industries, Bandaram Pharma, HRS Aluglaze and others, effective from January 2, … | |||||||||||||||
BSE revises price bands for 20 scrips including Aerpace Industries, Bandaram Pharma, HRS Aluglaze and others, effective from January 2, 2026.
| |||||||||||||||